As of 2025-12-16, the Relative Valuation of Bio Rad Laboratories Inc (BIO) is (734.29) USD. This relative valuation is based on P/E multiples. With the latest stock price at 307.92 USD, the upside of Bio Rad Laboratories Inc based on Relative Valuation is -338.5%.
The range of the Relative Valuation is (709.23) - (741.31) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 28.3x - 31.1x | 30.0x |
| Forward P/E multiples | 27.7x - 29.6x | 28.6x |
| Fair Price | (709.23) - (741.31) | (734.29) |
| Upside | -330.3% - -340.7% | -338.5% |
| Date | P/E |
| 2025-12-15 | -12.29 |
| 2025-12-12 | -12.30 |
| 2025-12-11 | -12.53 |
| 2025-12-10 | -12.57 |
| 2025-12-09 | -12.29 |
| 2025-12-08 | -12.31 |
| 2025-12-05 | -12.68 |
| 2025-12-04 | -12.77 |
| 2025-12-03 | -12.78 |
| 2025-12-02 | -12.71 |
| 2025-12-01 | -12.83 |
| 2025-11-28 | -12.96 |
| 2025-11-26 | -13.05 |
| 2025-11-25 | -13.26 |
| 2025-11-24 | -12.87 |
| 2025-11-21 | -12.64 |
| 2025-11-20 | -12.11 |
| 2025-11-19 | -12.16 |
| 2025-11-18 | -12.28 |
| 2025-11-17 | -12.13 |
| 2025-11-14 | -12.50 |
| 2025-11-13 | -12.64 |
| 2025-11-12 | -13.06 |
| 2025-11-11 | -12.50 |
| 2025-11-10 | -12.27 |
| 2025-11-07 | -12.19 |
| 2025-11-06 | -12.23 |
| 2025-11-05 | -12.37 |
| 2025-11-04 | -12.41 |
| 2025-11-03 | -12.43 |
| 2025-10-31 | -12.75 |
| 2025-10-30 | -12.15 |
| 2025-10-29 | -12.75 |
| 2025-10-28 | -13.18 |
| 2025-10-27 | -13.41 |
| 2025-10-24 | -13.56 |
| 2025-10-23 | -13.51 |
| 2025-10-22 | -13.33 |
| 2025-10-21 | -13.22 |
| 2025-10-20 | -12.84 |
| 2025-10-17 | -12.37 |
| 2025-10-16 | -12.47 |
| 2025-10-15 | -12.20 |
| 2025-10-14 | -12.17 |
| 2025-10-13 | -12.12 |
| 2025-10-10 | -11.88 |
| 2025-10-09 | -12.00 |
| 2025-10-08 | -12.08 |
| 2025-10-07 | -11.83 |
| 2025-10-06 | -12.34 |